Effects of amiodarone on serum TNF-α, IL6, IL8 and hemorheology in patients with congestive heart failure
Fei Guo,Xiaohui Liu,Xinmin Liu,Yang Guan,Jianzeng Dong
DOI: https://doi.org/10.3969/j.issn.1674-4055.2018.01.26
2018-01-01
Abstract:Objective To investigate the effects of amiodarone on serum TNF-α, IL-6, IL-8 and hemorheology in patients with congestive heart failure. Method A total of 94 hospitalized patients with CHF from March 2016 to March 2017 were selected. The patients were randomized divided into treatment group and control group, each group included 47 patients. Two groups were given routine clinical treatment for eight weeks, and the treatment group was additionally given amiodarone 200 mg. The levels of serum TNF-α, IL-6 and IL-8 were measured by ELISA, and the blood rheology index was measured by blood viscosity tester. Result The total effective rate was 91.49% in the treatment group, which was higher than that in the control group (72.34%), the difference was statistically significant (P<0.05). There was no significant difference in the levels of TNF-α, IL-6 and IL-8 between the two groups before treatment (P>0.05). After treatment, the levels of TNF-α, IL-6 and IL-8 in the treatment group were significantly lower than those in the control group(P<0.05). There was no significant difference in the hemorheology indexes between the two groups before treatment (P>0.05). After treatment, the levels of whole blood viscosity, plasma viscosity, ET, EAI, PAR, FIB and HCT were significantly lower in the treatment group than those in the control group (P<0.05). Conclusion Amiodarone in the treatment of CHF has good clinical effect, and it can effectively reduce the level of inflammatory factors in patients with CHF, improve blood flow rheology, worthy of clinical application.